ERIGO® Life- Control of Cardiovascular Parameters Via Verticalization and Simultaneous Mobilization
ERIGO®LIFE
ERIGO® Life - Study of Cardiovascular Parameters and Other Physiologic Parameters Under Verticalization and Simultaneous Mobilization of the Leg on Neurological Patients and Healthy Subjects
1 other identifier
interventional
30
1 country
2
Brief Summary
Early verticalization and stepping with the equipment of Hocoma ERIGO during monitoring of vital parameters. The device is already CE marked and, for the purposes of the study, will be used in accordance with the intended use (after-market clinical investigation).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable stroke
Started Apr 2010
Longer than P75 for not_applicable stroke
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2010
CompletedFirst Submitted
Initial submission to the registry
July 31, 2014
CompletedFirst Posted
Study publicly available on registry
October 20, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2015
CompletedNovember 18, 2015
November 1, 2015
4.9 years
July 31, 2014
November 17, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of participants with adverse event as a measure of safety and tolerability
Control of cardiovascular parameters at desired ranges at healthy and at patients
Up to 8 hours
Study Arms (1)
Single-arm study
OTHEREarly mobilization of patients after stroke or spinal cord injury. Monitoring of vital parameters during mobilization of healthy subjects
Interventions
The control of cardiovascular parameters within suitable ranges for healthy and neurological patients using verticalization, leg mobilization and electrical stimulation
Eligibility Criteria
You may qualify if:
- minimum 18 years old
- normal response to verbal instructions
- oxygen saturation of the blood at least 92%
- healthy german speaking men and women
- non-smoker
- heartbeat 40-100
- systolic blood pressure 120 to 220 mmHg
- in patients: post acute phase: stroke or other neurological functional disorder
You may not qualify if:
- severe contraction in the legs (Ashworth \>3)
- pregnancy
- acute pain syndrome
- severe cardio-pulmonary disease
- history of orthostatic dysregulation
- thrombophlebitis
- diabetes
- renal disease
- contraindication for electric stimulation (instable epilepsy, cancer, pacemaker, palliative care)
- weight \> 120kg
- height \> 210 cm
- skin lesions on legs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Swiss Federal Institute of Technologylead
- Zuercher Hoehenklinik Waldcollaborator
- Hocoma AG, Switzerlandcollaborator
Study Sites (2)
Zürcher Höhenklinik Wald
Wald, Canton of Zurich, 8636, Switzerland
ETH Zurich
Zurich, Canton of Zurich, 8091, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Robert Riener, Prof.Dr.-Ing
Swiss Federal Institut of Technology
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. med.
Study Record Dates
First Submitted
July 31, 2014
First Posted
October 20, 2014
Study Start
April 1, 2010
Primary Completion
March 1, 2015
Study Completion
March 1, 2015
Last Updated
November 18, 2015
Record last verified: 2015-11